Vanguard Group’s BG MEDICINE INC COM STK NEW BGMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-208,087
Closed -$458K 4213
2015
Q2
$458K Buy
208,087
+5,000
+2% +$14.2K ﹤0.01% 3887
2015
Q1
$658K Buy
203,087
+23,656
+13% +$72K ﹤0.01% 3754
2014
Q4
$331K Sell
179,431
-3,818
-2% -$6.38K ﹤0.01% 3824
2014
Q3
$399K Sell
183,249
-825
-0.4% -$2.76K ﹤0.01% 3776
2014
Q2
$773K Buy
184,074
+32,557
+21% +$154K ﹤0.01% 3555
2014
Q1
$1.16M Buy
151,517
+37,930
+33% +$210K ﹤0.01% 3406
2013
Q4
$473K Buy
113,587
+23,348
+26% +$67.9K ﹤0.01% 3612
2013
Q3
$332K Buy
90,239
+1,790
+2% +$7.54K ﹤0.01% 3614
2013
Q2
$471K Buy
+88,449
New +$589K ﹤0.01% 3499

Other funds holding BGMD

Vanguard Group's BGMD Position: Q3 2015 in Review

Vanguard Group sold out of BG MEDICINE INC COM STK NEW (BGMD) in Q3 2015, closing a stake of 208,087 shares — an estimated $458K sold.

Vanguard Group first reported a position in BGMD in Q2 2013 and held it in 9 quarters. The position peaked at $1.16M in Q1 2014. 2 funds tracked by Wall St. Rank hold BGMD as of Q3 2015.

  • Vanguard Group reported no remaining BG MEDICINE INC COM STK NEW position as of Q3 2015 after selling out during the quarter.
  • Vanguard Group sold 208,087 BG MEDICINE INC COM STK NEW shares in Q3 2015, an estimated $458K.
  • Vanguard Group first reported a position in BG MEDICINE INC COM STK NEW in Q2 2013 and held it in 9 quarters.
  • Vanguard Group's BG MEDICINE INC COM STK NEW position peaked at $1.16M in Q1 2014.
  • 2 funds tracked by Wall St. Rank held BG MEDICINE INC COM STK NEW as of Q3 2015.

Based on Vanguard Group's 13F filing for Q3 2015, filed 12 Nov 2015.